Fulcrum Therapeutics shares owned by UBS Group
Quarter-by-quarter ownership of Fulcrum Therapeutics (FULC) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Fulcrum Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Fulcrum Therapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Fulcrum Therapeutics by UBS Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $2.8M | 301k | 9.20 |
| 2025-06-30 | $930k | 135k | 6.88 |
| 2025-03-31 | $207k | 72k | 2.88 |
| 2024-12-31 | $364k | 77k | 4.70 |
| 2024-09-30 | $288k | 81k | 3.57 |
| 2024-06-30 | $1.2M | 191k | 6.20 |
| 2024-03-31 | $687k | 73k | 9.44 |
| 2023-12-31 | $204k | 30k | 6.75 |
| 2023-09-30 | $50k | 11k | 4.44 |
| 2023-06-30 | $105k | 32k | 3.30 |
| 2023-03-31 | $1.2k | 424 | 2.85 |
| 2022-12-31 | $28k | 3.8k | 7.28 |
| 2022-03-31 | $36k | 1.5k | 24.15 |
| 2021-12-31 | $15k | 825 | 18.18 |
| 2021-09-30 | $37k | 1.3k | 28.35 |
| 2021-06-30 | $10k | 942 | 10.62 |
| 2021-03-31 | $18k | 1.5k | 11.83 |
| 2020-12-31 | $4.0k | 330 | 12.12 |
| 2020-09-30 | $26k | 3.2k | 8.00 |
| 2020-06-30 | $78k | 4.3k | 18.00 |
| 2020-03-31 | $97k | 8.1k | 11.95 |
| 2019-12-31 | $98k | 6.1k | 16.00 |
| 2019-09-30 | $29k | 4.4k | 6.59 |